|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | |
| A61K 38/16 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2922876 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13856357.2 |
| Europos patento paraiškos padavimo data | 2013-11-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/071077 |
| Data | 2013-11-20 |
| (87) | Numeris | WO 2014/081872 |
| Data | 2014-05-30 |
| (30) | Numeris | Data | Šalis |
| 201261728649 P | 2012-11-20 | US |
| (72) |
NESTOR, John, J., US
|
| (73) |
Mederis Diabetes, LLC,
7515 Guinevere Drive, Sugar Land, Texas 77479,
US
|
| (54) | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |
| IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE |